Targeting replication stress in triple negative breast cancer treatment regimen: An emerging approach

被引：0
|
作者：
Rajamanickam, Subapriya
Park, Jun Hyoung
Bates, Kaitlyn
Timilsina, Santosh
Eedunuri, Vijay Kumar
Onyeagucha, Benjamin
Subbarayalu, Panneerdoss
Abdelfattah, Nourhan
Jung, Kwang Hwa
Favours, Edward
Mohammad, Tabrez A.
Chen, Hung-I Harry
Vadlamudi, Ratna K.
Chen, Yidong
Kaipparettu, Benny A.
Arbiser, Jack L.
Rao, Manjeet K.
机构：
[1] UT Hlth San Antonio, San Antonio, TX USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Emory Univ, Sch Med, Atlanta, GA, Ukraine
来源：
CANCER RESEARCH | 2018年 / 78卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-06-04
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer
    Singh, Sima
    Numan, Arshid
    Maddiboyina, Balaji
    Arora, Saahil
    Riadi, Yassine
    Md, Shadab
    Alhakamy, Nabil A.
    Kesharwani, Prashant
    DRUG DISCOVERY TODAY, 2021, 26 (07) : 1721 - 1727
  • [32] Current Treatment Landscape and Emerging Therapies for Metastatic Triple-Negative Breast Cancer
    Adel, Nelly G.
    AMERICAN JOURNAL OF MANAGED CARE, 2021, 27 (05): : S87 - S96
  • [33] Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
    Das, Sonia G.
    Pianetti, Stefania
    Sonenshein, Gail E.
    Mineva, Nora D.
    CANCER RESEARCH, 2017, 77
  • [34] Innovative Nanomaterials for Targeting Hypoxia to Improve Treatment for Triple-negative Breast Cancer
    Ray S.K.
    Mukherjee S.
    Recent Patents on Biotechnology, 2024, 18 (04) : 269 - 272
  • [35] Targeting LIFR enhances the activity of HDAC inhibitors for the treatment of triple negative breast cancer
    Viswanadhapalli, Suryavathi
    Li, Mengxing
    Santhamma, Bindu
    Pratap, Uday P.
    Luo, Yiliao
    Liu, Junhao
    Altwegg, Kristin A.
    Li, Xiaonan
    Yan, Hui
    Xu, Zhenming
    Brenner, Andrew
    Sareddy, Gangadhara R.
    Tekmal, Rajeshwar R.
    Nair, Hareesh B.
    Nickisch, Klaus J.
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2020, 80 (04)
  • [36] Natural compound targeting metabolism: A new insight for the treatment of triple negative breast cancer
    Arora, Ritu
    Schmitt, David
    McClellan, Steve
    Tan, Ming
    Dean-Colomb, Windy
    CANCER RESEARCH, 2014, 74 (19)
  • [37] Identification of Optimal Carboplatin Containing Regimen for Triple Negative Breast Cancer
    Rempel, Geoffrey J.
    Rim, Claire S.
    Hussein, Abdulkadir
    Bocicariu, Alina
    Kulkarni, Swati
    Gupta, Rasna
    Matthews, John
    Kay, Amin
    Porter, Lisa
    Hamm, Caroline
    CANCER RESEARCH, 2023, 83 (05)
  • [38] Current and emerging biologic therapies for triple negative breast cancer
    Shaikh, Saba S.
    Emens, Leisha A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (05) : 591 - 602
  • [39] Emerging Novel Therapeutics in Triple-Negative Breast Cancer
    Lyons, Tomas G.
    Traina, Tiffany A.
    BREAST CANCER METASTASIS AND DRUG RESISTANCE: CHALLENGES AND PROGRESS, 2ND EDITION, 2019, 1152 : 377 - 399
  • [40] Emerging Therapeutics for Patients with Triple-Negative Breast Cancer
    Elisa Agostinetto
    Daniel Eiger
    Kevin Punie
    Evandro de Azambuja
    Current Oncology Reports, 2021, 23
12345